Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Groppa, Liliana
EXPAND, NCT05516979 / 2022-001828-15: A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment	Completed	2	127	RoW	100 mg AP1189, AP1189 tablets for oral use, Placebo	SynAct Pharma Aps, NBCD A/S	Rheumatoid Arthritis	07/23	07/23
RESOLVE, NCT05604885 / 2022-002605-26: A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate	Completed	2	125	RoW	AP1189, 60 mg, AP1189, 80 mg, AP1189, 100 mg, Placebo	SynAct Pharma Aps, NBCD A/S	Rheumatoid Arthritis	08/23	08/23
NCT06005220: SBD121, a Synbiotic Medical Food for RA Management	Recruiting	N/A	140	Europe, RoW	SBD121, Placebo	Solarea Bio, Inc	Rheumatoid Arthritis	06/25	07/25